Broader storage conditions for Pfizer vaccine bring GPs into the fold TGA-approved guideline changes have opened the possibility for general practices to take part in the rollout of the mRNA vaccine.
No legal risk for GPs administering AstraZeneca vaccine: Health Minister Greg Hunt has moved to reassure practitioners amid reports GPs stopped offering AstraZeneca to under-50s following recent ATAGI recommendations.
Research reveals mental health toll for COVID survivors One in three people who contracted COVID-19 were diagnosed with a neurological or psychiatric condition within six months of infection.
Brendan Murphy says most GPs ‘incredibly happy’ with vaccine rollout The DoH Secretary acknowledges ‘a couple of instances’ of GPs being upset receiving fewer doses, but said supply issues are to blame.
European regulator finds possible link between vaccine and blood clots UPDATED: The European Medicines Agency says it has found a possible link between AstraZeneca’s COVID-19 vaccine and rare blood clotting issues in adults.
ATAGI issues GPs with guidance for clotting condition ‘likely’ linked to COVID vaccine The national advisory body is urging vaccine providers to be aware of post-vaccination warning signs, including new onset of severe persistent headache that is not settling with analgesia.
Who is seeking pharmacotherapy treatment for opioid dependence? Annual data examines who, where and why on a ‘snapshot day’ in 2020, and how treatment has progressed.
Calls for global strategy of ‘maximum suppression’ of COVID-19 New variants ‘have changed the game’ and vaccines alone will not be enough, according to a group of international experts.
GPs ‘in the dark’ over aged care vaccination delays Failure to reach vaccination targets and a lack of communication has left GPs concerned and unable to prepare for the influenza vaccine rollout.
mRNA COVID vaccine ‘well-tolerated’ in adolescents According to Pfizer, its vaccine is safe and effective in children as young as 12, which could be crucial for herd immunity.